Rituximab ( Rituxan sup > ) is a monoclonal antibody that is widely used for lymphoma.
利妥西单抗 ( 美罗华 ) 是广泛应用于淋巴瘤的单克隆抗体.
互联网
Patients get rituximab through infusion into a vein ( IV ) at the oncologist's office or clinic.
患者可在肿瘤专家的办公室或门诊接受 静脉 注入美罗华.
互联网
Objective: To elucidate the efficacy and adverse drug reaction of rituximab in treatment of non - Hodgkin's lymphoma.
目的: 阐述利妥昔单抗对于 非 霍奇金淋巴瘤的疗效和药物的不良反应,并尝试探讨其药物经济学.
互联网